Global Implantable Drug-Eluting Devices Market Research Report 2022 - Market Study Report

Global Implantable Drug-Eluting Devices Market Research Report 2022

Report Format: PDF | Report ID: 5379074 | Published Date: July 22, 2022

Choose License
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Implantable Drug Infusion Pumps
    Intraocular Drug-Eluting Devices
    Contraceptive Drug-Eluting Devices
    Drug-Eluting Stents
    Others
Segment by Application
    Diabetes
    Contraception
    HIV/AIDS Prevention
    Chronic Pain Management
    Cardiovascular
    Ophthalmology
    Oncology
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Pfizer
    Medtronic
    Merck
    Bayer AG
    Johnson & Johnson
    Abbott
    Surmodics
    Boston Scientific Corporation
    Titan Pharmaceuticals, Inc.
    BIOTRONIK
    Allergan
    Bausch & Lomb
    REVA Medical
    MicroPort Medical
1 Implantable Drug-Eluting Devices Market Overview
    1.1 Product Overview and Scope of Implantable Drug-Eluting Devices
    1.2 Implantable Drug-Eluting Devices Segment by Type
        1.2.1 Global Implantable Drug-Eluting Devices Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Implantable Drug Infusion Pumps
        1.2.3 Intraocular Drug-Eluting Devices
        1.2.4 Contraceptive Drug-Eluting Devices
        1.2.5 Drug-Eluting Stents
        1.2.6 Others
    1.3 Implantable Drug-Eluting Devices Segment by Application
        1.3.1 Global Implantable Drug-Eluting Devices Sales Comparison by Application: (2022-2028)
        1.3.2 Diabetes
        1.3.3 Contraception
        1.3.4 HIV/AIDS Prevention
        1.3.5 Chronic Pain Management
        1.3.6 Cardiovascular
        1.3.7 Ophthalmology
        1.3.8 Oncology
        1.3.9 Others
    1.4 Global Implantable Drug-Eluting Devices Market Size Estimates and Forecasts
        1.4.1 Global Implantable Drug-Eluting Devices Revenue 2017-2028
        1.4.2 Global Implantable Drug-Eluting Devices Sales 2017-2028
        1.4.3 Implantable Drug-Eluting Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Implantable Drug-Eluting Devices Market Competition by Manufacturers
    2.1 Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Implantable Drug-Eluting Devices Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
    2.5 Implantable Drug-Eluting Devices Market Competitive Situation and Trends
        2.5.1 Implantable Drug-Eluting Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Implantable Drug-Eluting Devices Players Market Share by Revenue
        2.5.3 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Drug-Eluting Devices Retrospective Market Scenario by Region
    3.1 Global Implantable Drug-Eluting Devices Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Implantable Drug-Eluting Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Implantable Drug-Eluting Devices Market Facts & Figures by Country
        3.3.1 North America Implantable Drug-Eluting Devices Sales by Country
        3.3.2 North America Implantable Drug-Eluting Devices Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Implantable Drug-Eluting Devices Market Facts & Figures by Country
        3.4.1 Europe Implantable Drug-Eluting Devices Sales by Country
        3.4.2 Europe Implantable Drug-Eluting Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Implantable Drug-Eluting Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Implantable Drug-Eluting Devices Sales by Region
        3.5.2 Asia Pacific Implantable Drug-Eluting Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Implantable Drug-Eluting Devices Market Facts & Figures by Country
        3.6.1 Latin America Implantable Drug-Eluting Devices Sales by Country
        3.6.2 Latin America Implantable Drug-Eluting Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Implantable Drug-Eluting Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Implantable Drug-Eluting Devices Sales by Country
        3.7.2 Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Implantable Drug-Eluting Devices Historic Market Analysis by Type
    4.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    4.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2017-2022)
    4.3 Global Implantable Drug-Eluting Devices Price by Type (2017-2022)
5 Global Implantable Drug-Eluting Devices Historic Market Analysis by Application
    5.1 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    5.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2017-2022)
    5.3 Global Implantable Drug-Eluting Devices Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Pfizer Implantable Drug-Eluting Devices Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 Medtronic
        6.2.1 Medtronic Corporation Information
        6.2.2 Medtronic Description and Business Overview
        6.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Medtronic Implantable Drug-Eluting Devices Product Portfolio
        6.2.5 Medtronic Recent Developments/Updates
    6.3 Merck
        6.3.1 Merck Corporation Information
        6.3.2 Merck Description and Business Overview
        6.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Merck Implantable Drug-Eluting Devices Product Portfolio
        6.3.5 Merck Recent Developments/Updates
    6.4 Bayer AG
        6.4.1 Bayer AG Corporation Information
        6.4.2 Bayer AG Description and Business Overview
        6.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bayer AG Implantable Drug-Eluting Devices Product Portfolio
        6.4.5 Bayer AG Recent Developments/Updates
    6.5 Johnson & Johnson
        6.5.1 Johnson & Johnson Corporation Information
        6.5.2 Johnson & Johnson Description and Business Overview
        6.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolio
        6.5.5 Johnson & Johnson Recent Developments/Updates
    6.6 Abbott
        6.6.1 Abbott Corporation Information
        6.6.2 Abbott Description and Business Overview
        6.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Abbott Implantable Drug-Eluting Devices Product Portfolio
        6.6.5 Abbott Recent Developments/Updates
    6.7 Surmodics
        6.6.1 Surmodics Corporation Information
        6.6.2 Surmodics Description and Business Overview
        6.6.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Surmodics Implantable Drug-Eluting Devices Product Portfolio
        6.7.5 Surmodics Recent Developments/Updates
    6.8 Boston Scientific Corporation
        6.8.1 Boston Scientific Corporation Corporation Information
        6.8.2 Boston Scientific Corporation Description and Business Overview
        6.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolio
        6.8.5 Boston Scientific Corporation Recent Developments/Updates
    6.9 Titan Pharmaceuticals, Inc.
        6.9.1 Titan Pharmaceuticals, Inc. Corporation Information
        6.9.2 Titan Pharmaceuticals, Inc. Description and Business Overview
        6.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolio
        6.9.5 Titan Pharmaceuticals, Inc. Recent Developments/Updates
    6.10 BIOTRONIK
        6.10.1 BIOTRONIK Corporation Information
        6.10.2 BIOTRONIK Description and Business Overview
        6.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 BIOTRONIK Implantable Drug-Eluting Devices Product Portfolio
        6.10.5 BIOTRONIK Recent Developments/Updates
    6.11 Allergan
        6.11.1 Allergan Corporation Information
        6.11.2 Allergan Implantable Drug-Eluting Devices Description and Business Overview
        6.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Allergan Implantable Drug-Eluting Devices Product Portfolio
        6.11.5 Allergan Recent Developments/Updates
    6.12 Bausch & Lomb
        6.12.1 Bausch & Lomb Corporation Information
        6.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Description and Business Overview
        6.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolio
        6.12.5 Bausch & Lomb Recent Developments/Updates
    6.13 REVA Medical
        6.13.1 REVA Medical Corporation Information
        6.13.2 REVA Medical Implantable Drug-Eluting Devices Description and Business Overview
        6.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 REVA Medical Implantable Drug-Eluting Devices Product Portfolio
        6.13.5 REVA Medical Recent Developments/Updates
    6.14 MicroPort Medical
        6.14.1 MicroPort Medical Corporation Information
        6.14.2 MicroPort Medical Implantable Drug-Eluting Devices Description and Business Overview
        6.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 MicroPort Medical Implantable Drug-Eluting Devices Product Portfolio
        6.14.5 MicroPort Medical Recent Developments/Updates
7 Implantable Drug-Eluting Devices Manufacturing Cost Analysis
    7.1 Implantable Drug-Eluting Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
    7.4 Implantable Drug-Eluting Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Implantable Drug-Eluting Devices Distributors List
    8.3 Implantable Drug-Eluting Devices Customers
9 Implantable Drug-Eluting Devices Market Dynamics
    9.1 Implantable Drug-Eluting Devices Industry Trends
    9.2 Implantable Drug-Eluting Devices Market Drivers
    9.3 Implantable Drug-Eluting Devices Market Challenges
    9.4 Implantable Drug-Eluting Devices Market Restraints
10 Global Market Forecast
    10.1 Implantable Drug-Eluting Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Implantable Drug-Eluting Devices by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Implantable Drug-Eluting Devices by Type (2023-2028)
    10.2 Implantable Drug-Eluting Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Implantable Drug-Eluting Devices by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Implantable Drug-Eluting Devices by Application (2023-2028)
    10.3 Implantable Drug-Eluting Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Implantable Drug-Eluting Devices by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Implantable Drug-Eluting Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Implantable Drug-Eluting Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Implantable Drug-Eluting Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Implantable Drug-Eluting Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Implantable Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2021 Table 5. Global Implantable Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2017-2022) Table 7. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites and Area Served Table 11. Manufacturers Implantable Drug-Eluting Devices Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Implantable Drug-Eluting Devices Sales by Region (2017-2022) & (K Units) Table 16. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2022) Table 17. Global Implantable Drug-Eluting Devices Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2022) Table 19. North America Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units) Table 20. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2022) Table 21. North America Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2022) Table 23. Europe Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units) Table 24. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2022) Table 25. Europe Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2022) Table 31. Latin America Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units) Table 32. Latin America Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2022) Table 33. Latin America Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2017-2022) Table 39. Global Implantable Drug-Eluting Devices Sales by Type (2017-2022) & (K Units) Table 40. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2017-2022) Table 41. Global Implantable Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Implantable Drug-Eluting Devices Revenue Share by Type (2017-2022) Table 43. Global Implantable Drug-Eluting Devices Price by Type (2017-2022) & (USD/Unit) Table 44. Global Implantable Drug-Eluting Devices Sales (K Units) by Application (2017-2022) Table 45. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2017-2022) Table 46. Global Implantable Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Implantable Drug-Eluting Devices Revenue Share by Application (2017-2022) Table 48. Global Implantable Drug-Eluting Devices Price by Application (2017-2022) & (USD/Unit) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Pfizer Implantable Drug-Eluting Devices Product Table 53. Pfizer Recent Developments/Updates Table 54. Medtronic Corporation Information Table 55. Medtronic Description and Business Overview Table 56. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Medtronic Implantable Drug-Eluting Devices Product Table 58. Medtronic Recent Developments/Updates Table 59. Merck Corporation Information Table 60. Merck Description and Business Overview Table 61. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Merck Implantable Drug-Eluting Devices Product Table 63. Merck Recent Developments/Updates Table 64. Bayer AG Corporation Information Table 65. Bayer AG Description and Business Overview Table 66. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Bayer AG Implantable Drug-Eluting Devices Product Table 68. Bayer AG Recent Developments/Updates Table 69. Johnson & Johnson Corporation Information Table 70. Johnson & Johnson Description and Business Overview Table 71. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Johnson & Johnson Implantable Drug-Eluting Devices Product Table 73. Johnson & Johnson Recent Developments/Updates Table 74. Abbott Corporation Information Table 75. Abbott Description and Business Overview Table 76. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Abbott Implantable Drug-Eluting Devices Product Table 78. Abbott Recent Developments/Updates Table 79. Surmodics Corporation Information Table 80. Surmodics Description and Business Overview Table 81. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Surmodics Implantable Drug-Eluting Devices Product Table 83. Surmodics Recent Developments/Updates Table 84. Boston Scientific Corporation Corporation Information Table 85. Boston Scientific Corporation Description and Business Overview Table 86. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Boston Scientific Corporation Implantable Drug-Eluting Devices Product Table 88. Boston Scientific Corporation Recent Developments/Updates Table 89. Titan Pharmaceuticals, Inc. Corporation Information Table 90. Titan Pharmaceuticals, Inc. Description and Business Overview Table 91. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Table 93. Titan Pharmaceuticals, Inc. Recent Developments/Updates Table 94. BIOTRONIK Corporation Information Table 95. BIOTRONIK Description and Business Overview Table 96. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. BIOTRONIK Implantable Drug-Eluting Devices Product Table 98. BIOTRONIK Recent Developments/Updates Table 99. Allergan Corporation Information Table 100. Allergan Description and Business Overview Table 101. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Allergan Implantable Drug-Eluting Devices Product Table 103. Allergan Recent Developments/Updates Table 104. Bausch & Lomb Corporation Information Table 105. Bausch & Lomb Description and Business Overview Table 106. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Bausch & Lomb Implantable Drug-Eluting Devices Product Table 108. Bausch & Lomb Recent Developments/Updates Table 109. REVA Medical Corporation Information Table 110. REVA Medical Description and Business Overview Table 111. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. REVA Medical Implantable Drug-Eluting Devices Product Table 113. REVA Medical Recent Developments/Updates Table 114. MicroPort Medical Corporation Information Table 115. MicroPort Medical Description and Business Overview Table 116. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. MicroPort Medical Implantable Drug-Eluting Devices Product Table 118. MicroPort Medical Recent Developments/Updates Table 119. Production Base and Market Concentration Rate of Raw Material Table 120. Key Suppliers of Raw Materials Table 121. Implantable Drug-Eluting Devices Distributors List Table 122. Implantable Drug-Eluting Devices Customers List Table 123. Implantable Drug-Eluting Devices Market Trends Table 124. Implantable Drug-Eluting Devices Market Drivers Table 125. Implantable Drug-Eluting Devices Market Challenges Table 126. Implantable Drug-Eluting Devices Market Restraints Table 127. Global Implantable Drug-Eluting Devices Sales Forecast by Type (2023-2028) & (K Units) Table 128. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Type (2023-2028) Table 129. Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2023-2028) & (US$ Million) Table 130. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2023-2028) Table 131. Global Implantable Drug-Eluting Devices Sales Forecast by Application (2023-2028) & (K Units) Table 132. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Application (2023-2028) Table 133. Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2023-2028) & (US$ Million) Table 134. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Application (2023-2028) Table 135. Global Implantable Drug-Eluting Devices Sales Forecast by Region (2023-2028) & (K Units) Table 136. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Region (2023-2028) Table 137. Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2023-2028) & (US$ Million) Table 138. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Region (2023-2028) Table 139. Research Programs/Design for This Report Table 140. Key Data Information from Secondary Sources Table 141. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Implantable Drug-Eluting Devices Figure 2. Global Implantable Drug-Eluting Devices Market Share by Type in 2021 & 2028 Figure 3. Implantable Drug Infusion Pumps Product Picture Figure 4. Intraocular Drug-Eluting Devices Product Picture Figure 5. Contraceptive Drug-Eluting Devices Product Picture Figure 6. Drug-Eluting Stents Product Picture Figure 7. Others Product Picture Figure 8. Global Implantable Drug-Eluting Devices Market Share by Application in 2021 & 2028 Figure 9. Diabetes Figure 10. Contraception Figure 11. HIV/AIDS Prevention Figure 12. Chronic Pain Management Figure 13. Cardiovascular Figure 14. Ophthalmology Figure 15. Oncology Figure 16. Others Figure 17. Global Implantable Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 18. Global Implantable Drug-Eluting Devices Market Size (2017-2028) & (US$ Million) Figure 19. Global Implantable Drug-Eluting Devices Sales (2017-2028) & (K Units) Figure 20. Implantable Drug-Eluting Devices Sales Share by Manufacturers in 2021 Figure 21. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers in 2021 Figure 22. The Global 5 and 10 Largest Implantable Drug-Eluting Devices Players: Market Share by Revenue in 2021 Figure 23. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 24. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2017-2022) Figure 25. Global Implantable Drug-Eluting Devices Sales Market Share by Region in 2021 Figure 26. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2017-2022) Figure 27. Global Implantable Drug-Eluting Devices Revenue Market Share by Region in 2021 Figure 28. U.S. Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Canada Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Germany Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. France Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. U.K. Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Italy Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Russia Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. China Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Japan Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. South Korea Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. India Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Australia Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Taiwan Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Indonesia Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Thailand Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Malaysia Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Philippines Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Vietnam Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Mexico Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Brazil Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. Argentina Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 49. Turkey Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 50. Saudi Arabia Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 51. U.A.E Implantable Drug-Eluting Devices Revenue Growth Rate (2017-2022) & (US$ Million) Figure 52. Sales Market Share of Implantable Drug-Eluting Devices by Type (2017-2022) Figure 53. Manufacturing Cost Structure of Implantable Drug-Eluting Devices Figure 54. Manufacturing Process Analysis of Implantable Drug-Eluting Devices Figure 55. Implantable Drug-Eluting Devices Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us